Back
Cleveland-Cliffs, Inc. Vs. Viking Therapeutics, Inc. Industry Stock Comparison
Sell
39
CLF
Cleveland-Cliffs, Inc.
Last Price:
$13.24
Seasonality Move:
8.47%
Sell
37
VKTX
Viking Therapeutics, Inc.
Last Price:
$35.15
Seasonality Move:
33.2%
Sell
39
Cleveland-Cliffs, Inc. (CLF)
is a Sell
Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?
-
The current Cleveland-Cliffs, Inc. [CLF] share price is $12.98. The Score for CLF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Viking Therapeutics, Inc. [VKTX] share price is $33.95. The Score for VKTX is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLF Stock Price Chart
What is Cleveland-Cliffs, Inc.'s stock price today?
-
The Cleveland-Cliffs, Inc. share price today is $12.98Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLF is experiencing slight selling pressure.
VKTX Stock Price Chart
What is Viking Therapeutics, Inc.'s stock price today?
-
The Viking Therapeutics, Inc. share price today is $33.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
CLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.27 | Buy |
| Relative Strength Index (14 RSI): | 56.86 | Buy |
| Chaikin Money Flow: | -6088078 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.39 - 13.07) | Buy |
| Bollinger Bands (100): | (10.42 - 13.12) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.82 | Buy |
| Relative Strength Index (14 RSI): | 40.78 | Sell |
| Chaikin Money Flow: | -1768548 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.73 - 38.07) | Sell |
| Bollinger Bands (100): | (27.49 - 37.83) | Buy |
CLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.85 | Buy |
| 20-day SMA: | 12.56 | Buy |
| 50-day SMA: | 12.45 | Buy |
| 200-day SMA: | 10.02 | Buy |
| 8-day EMA: | 12.84 | Buy |
| 20-day EMA: | 12.56 | Buy |
| 50-day EMA: | 12.23 | Buy |
| 200-day EMA: | 11.22 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.15 | Sell |
| 20-day SMA: | 35.99 | Sell |
| 50-day SMA: | 35.96 | Sell |
| 200-day SMA: | 30.15 | Buy |
| 8-day EMA: | 13.47 | Buy |
| 20-day EMA: | 6.19 | Buy |
| 50-day EMA: | 2.62 | Buy |
| 200-day EMA: | 0.68 | Buy |
Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.60 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $2.68 per share.
Viking Therapeutics, Inc. Earnings Growth & VKTX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.65 per share, and a decrease next year of $1.11 per share.
Cleveland-Cliffs, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||